NNVC Stock DD NanoViricides, Inc. 08/05/2014 15:51:45

Posted On: 08/05/2014 4:51:48 PM

Post# of 250679

Posted By: Rosner

NNVC NanoViricides, Inc. $NNVC Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=NNVC&...mp;yt0=Go!

Last Updated: 08/05/2014 15:51:41

Current Price and Quotes
Last Price 3.99
Previous Close 4.23 Open 4.25
Daily Range 3.92 - 4.25 52wk Range 2.67 - 7.59
Volume 305,694 Dividend N/A
Average Vol (3m) 300,141 Yield N/A

Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 4,293 4,266 4,156 3,205
Sales, General and Admin. 2,297 1,816 2,274 1,735
Non-Recurring Items - - - -
Other - - - -
Operating Income (6,590) (6,082) (6,429) (4,940)
Income From Continuing Operations

Add'l Income/Expense Items (2,108) (125) (48) 196
Earnings Before Interest and Tax (8,699) (6,207) (6,477) (4,744)
Interest Expense 177 - - -
Earnings Before Tax (8,876) (6,207) (6,477) (4,744)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (8,876) (6,207) (6,477) (4,744)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (8,876) (6,207) (6,477) (4,744)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (8,876) (6,207) (6,477) (4,744)

Recent News

Aug 4, 2014 NanoViricides to Restart its Anti-Ebola Virus Drug Development Program
Jul 23, 2014 NanoViricides President Dr. Diwan was an Invited Participant at the Prestigious CEO Roundtable
Jul 22, 2014 NanoViricides Inc. Celebrated the Grand Opening of Its New R&D and cGMP Pilot Manufacturing Facility with Congressman Jim Himes as the Chief Guest Yesterday
Jul 14, 2014 NanoViricides President Dr. Diwan Presented FluCide Data at the 3rd Annual Influenza Conference held by GTC Bio on Friday, July 11
Jul 2, 2014 NanoViricides Reports that its Director Dr. Milton Boniuk, a Director, Has Invested $5M into the Company in a Convertible Debenture
Jun 25, 2014 NanoViricides Reports That a Certificate of Occupancy Has Been Issued for the New cGMP Manufacturing and R&D Facility in Shelton, CT
Jun 19, 2014 NanoViricides President Dr. Diwan to Present at the Wall Street Analyst Forum Today, June 19th, in New York City
Jun 16, 2014 NanoViricides, Inc. Reports That NNVC is in the Preliminary Additions List of The Russell Global, The Russell 3000, The Russell 2000 and the Russell Microcap Indexes
Jun 4, 2014 NanoViricides CEO Dr. Seymour to Present at the LD Micro Invitational Conference Today, June 4th
May 19, 2014 NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates

(0)